Cargando…

The impact of high-risk and chronic opioid use among commercially insured endometriosis patients on health care resource utilization and costs in the United States

OBJECTIVES: Evaluate all-cause and endometriosis-related health care resource utilization and costs among newly diagnosed endometriosis patients with high-risk versus low-risk opioid use or patients with chronic versus non-chronic opioid use. METHODS: A retrospective analysis of IBM MarketScan(®) Co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Estes, Stephanie J, Soliman, Ahmed M, Zivkovic, Marko, Chopra, Divyan, Zhu, Xuelian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Primary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768844/ https://www.ncbi.nlm.nih.gov/pubmed/33357086 http://dx.doi.org/10.1177/1745506520965898

Ejemplares similares

Healthcare Resource Use and Costs Associated with Opioid Initiation Among Patients with Newly Diagnosed Endometriosis with Commercial Insurance in the USA
por: Estes, Stephanie J., et al.
Publicado: (2020)

Impact of Endometriosis Diagnostic Delays on Healthcare Resource Utilization and Costs
por: Surrey, Eric, et al.
Publicado: (2020)

Healthcare Utilization and Cost Burden of Porphyria in Commercially Insured Adults in the United States
por: Elsaid, Mohamed I., et al.
Publicado: (2020)

Healthcare Resource Utilization and Costs Among Commercially Insured Patients With Advanced or Recurrent Endometrial Cancer Initiating First-Line Therapy in the United States
por: Kobayashi, Monica, et al.
Publicado: (2023)

Direct Costs of Opioid Abuse in an Insured Population in the United States
por: White, Alan G., et al.
Publicado: (2005)

Direct Costs of Opioid Abuse in an Insured Population in the United States
por: WHITE, ALAN G., et al.
Publicado: (2020)

Utilization and Costs of Compounded Medications for Commercially Insured Patients, 2012-2013
por: McPherson, Timothy, et al.
Publicado: (2016)

Real-world treatment modalities, health care resource utilization, and costs among commercially insured patients with newly diagnosed major depressive disorder in the United States
por: Pizzicato, Lia N, et al.
Publicado: (2023)

Utilization and Costs of Gender-Affirming Care in a Commercially Insured Transgender Population
por: Baker, Kellan, et al.
Publicado: (2022)

A retrospective analysis to estimate the healthcare resource utilization and cost associated with treatment-resistant depression in commercially insured US patients
por: Li, Gang, et al.
Publicado: (2020)

Healthcare resource utilization and costs before and after long-acting injectable antipsychotic initiation in commercially insured young adults with schizophrenia
por: Fu, Alex Z., et al.
Publicado: (2022)

Changes in Healthcare Resource Use and Costs in Commercially Insured Insomnia Patients Initiating Suvorexant
por: Kale, Hrishikesh P., et al.
Publicado: (2021)

The Hidden Cost of the Opioid Epidemic in the United States: Drug Screening in Insurance Claims
por: Day-Storms, Jeremy J., et al.
Publicado: (2021)

Utility of postintubation chest radiographs in the intensive care unit
por: Lotano, Ramya, et al.
Publicado: (2000)

Geographic Variation in the Use of Gabapentinoids and Opioids for Pain in a Commercially Insured Adult Population in the United States
por: Zhao, Danni, et al.
Publicado: (2022)

Treatment patterns, adverse events, healthcare resource use and costs among commercially insured patients with mantle cell lymphoma in the United States
por: Kabadi, Shaum M., et al.
Publicado: (2019)

Hospital care for opioid use disorder in pregnancy: Challenges and opportunities identified from a Minnesota survey
por: Dopp, Alana, et al.
Publicado: (2020)

Analyzing the use and impact of elexacaftor/tezacaftor/ivacaftor on total cost of care and other health care resource utilization in a commercially insured population
por: Smith, Spenser, et al.
Publicado: (2022)

Direct and Indirect Costs of Infectious Conjunctivitis in a Commercially Insured Population in the United States
por: Pepose, Jay S, et al.
Publicado: (2020)

Health Care Costs of Anal Cancer in a Commercially Insured Population in the United States
por: Wu, Chi-Fang, et al.
Publicado: (2018)

Dose patterns in commercially insured subjects chronically exposed to opioids: a large cohort study in the United States
por: Cepeda, Maria Soledad, et al.
Publicado: (2010)

Association of Criminal Statutes for Opioid Use Disorder With Prevalence and Treatment Among Pregnant Women With Commercial Insurance in the United States
por: Gressler, Laura E., et al.
Publicado: (2019)

Opioid and benzodiazepine dispensing and co-dispensing patterns among commercially insured pregnant women in the United States, 2007–2015
por: Qato, Danya M., et al.
Publicado: (2021)

Clinical and economic burden of prescribing tramadol and other opioids for patients with osteoarthritis in a commercially insured population in the United States
por: Silverman, Stuart, et al.
Publicado: (2022)

Naloxone Prescriptions Among Commercially Insured Individuals at High Risk of Opioid Overdose
por: Follman, Sarah, et al.
Publicado: (2019)

Impact of Oxycodone HCl Extended-release Formulary Restrictions on Extended-release Opioid Market Share, Healthcare Resource Utilization and Costs in Commercial and Medicare Plans
por: Wade, Rolin L., et al.
Publicado: (2017)

Endometriosis and Opioid Receptors: Are Opioids a Possible/Promising Treatment for Endometriosis?
por: Guan, Qihui, et al.
Publicado: (2023)

Genetic polymorphisms of Vascular Endothelial Growth Factor (VEGF) associated with endometriosis in Nigerian women
por: Babah, Ochuwa Adiketu, et al.
Publicado: (2021)

Treatment Patterns and Health Care Costs in Commercially Insured Patients with Follicular Lymphoma
por: Fowler, Nathan H., et al.
Publicado: (2020)

Reproductive health care utilization among refugees in Jordan: Provisional support and domestic violence
por: Pierce, Hayley
Publicado: (2019)

Burden of Endometriosis: Infertility, Comorbidities, and Healthcare Resource Utilization
por: Eisenberg, Vered H., et al.
Publicado: (2022)

Wilson’s Disease: An Analysis of Health Care Use and Cost Burden of Commercially Insured Adults in the United States
por: Rustgi, Vinod K., et al.
Publicado: (2021)

Scaling up family planning in Sierra Leone: A prospective cost–benefit analysis
por: Keen, Sarah, et al.
Publicado: (2017)

Pricing in commercial dental insurance and provider markets
por: Nasseh, Kamyar, et al.
Publicado: (2020)

Frequency of Early Refills for Opioids in the United States
por: Kern, David M, et al.
Publicado: (2020)

Impact of discontinuity in health insurance on resource utilization
por: Banerjee, Ritesh, et al.
Publicado: (2010)

Prevalence, treatment patterns, and healthcare resource utilization in Medicare and commercially insured non-dialysis-dependent chronic kidney disease patients with and without anemia in the United States
por: St. Peter, Wendy L., et al.
Publicado: (2018)

Alcohol-Attributable Medical Costs in Commercially Insured and Medicaid Populations
por: Ozluk, Pelin, et al.
Publicado: (2022)

Health Care Resource Utilization in Commercially Insured Patients Undergoing Anterior Cervical Discectomy and Fusion for Degenerative Cervical Pathology
por: Marrache, Majd, et al.
Publicado: (2020)

Reasons for the utilization of the services of traditional birth attendants during childbirth: A qualitative study in Northern Ghana
por: Tabong, Philip Teg-Nefaah, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rh64pct8o6ci012hpgu5ubr24k